Aclaris Therapeutics
Aclaris Therapeutics is a biopharmaceutical company focused on developing treatments for immuno-inflammatory conditions using its proprietary KINect® technology platform.
Company Overview
Aclaris Therapeutics is a biopharmaceutical company dedicated to translating scientific discovery into treatments for immuno-inflammatory conditions. The company's headquarters are located in Wayne, PA, with an additional location in St. Louis, MO. Aclaris Therapeutics focuses on addressing treatment gaps in conditions such as rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, and inflammatory bowel disease.
Proprietary Technology Platform: KINect®
Aclaris Therapeutics employs the proprietary KINect® technology platform for the development of clinical candidates targeting difficult-to-drug kinases. This platform underpins the company's drug development pipeline, enabling the creation of investigational drugs aimed at treating various immuno-inflammatory conditions. The KINect® platform represents a core element of Aclaris Therapeutics' approach to innovation and therapeutic development.
Drug Development Pipeline
Aclaris Therapeutics has a robust drug development pipeline that includes investigational drugs developed internally using the KINect® technology platform. This pipeline is focused on addressing unmet medical needs in immuno-inflammatory conditions. The company actively seeks strategic partners for business development and research collaborations to further advance their therapeutic candidates through the stages of clinical development.
Commitment to Scientist Development
Aclaris Therapeutics supports the growth of young scientists through its Scientist Development Program. This initiative is designed for recent college graduates with 4-year degrees and aims to foster the development of scientific talent. The company also has a partnership with Harris-Stowe State University to promote diversity in STEM fields, particularly in the St. Louis area, thereby bridging the gap for under-represented minorities in STEM jobs.
Community and Research Support
Aclaris Therapeutics is committed to supporting research initiatives and community-building efforts through investigator-initiated studies and charitable contributions. The company believes in fostering a collaborative research environment and providing resources to advance scientific discovery and therapeutic development in the field of immuno-inflammatory conditions.
